Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2023 | Updates in the treatment of genitourinary cancers

Viktor Grünwald, MD, PhD, University Hospital Essen, Essen Germany, discusses recent trial findings revealing potential improvements to the treatment of patients with genitourinary cancers, specifically urothelial carcinoma. Dr Grünwald discusses the utilization of nivolumab in standard chemotherapy regimens, and the doublet combination of enfortumab vedotin and pembrolizumab. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.